Register
Study shows fewer relapses with fingolimod vs interferon beta-1a in pediatric multiple sclerosis |
Journal Updates
eMediNexus Coverage from: 
Study shows fewer relapses with fingolimod vs interferon beta-1a in pediatric multiple sclerosis
eMediNexus,  17 September 2018
remove_red_eye 623 Views
#Neurology #Pediatrics #Psychiatry

0 Read Comments                

Among pediatric patients with relapsing multiple sclerosis, fingolimod was associated with a lower rate of relapse and less accumulation of lesions on MRI over a 2-year period than interferon beta-1a but was associated with a higher rate of serious adverse events.
To continue reading this article
Sign in with Medtalks

Continue reading your article with a eMediNexus account.
Free Membership!